Search by Drug Name or NDC
NDC 00904-5769-60 mapap arthritis pain 650 mg/1 Details
mapap arthritis pain 650 mg/1
mapap arthritis pain is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is ACETAMINOPHEN.
MedlinePlus Drug Summary
Acetaminophen is used to relieve mild to moderate pain from headaches, muscle aches, menstrual periods, colds and sore throats, toothaches, backaches, and reactions to vaccinations (shots), and to reduce fever. Acetaminophen may also be used to relieve the pain of osteoarthritis (arthritis caused by the breakdown of the lining of the joints). Acetaminophen is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers). It works by changing the way the body senses pain and by cooling the body.
Related Packages: 00904-5769-60Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acetaminophen
Product Information
NDC | 00904-5769 |
---|---|
Product ID | 0904-5769_21078c0d-76b8-4596-9c4e-a9c1f8a84958 |
Associated GPIs | 64200010000420 |
GCN Sequence Number | 022123 |
GCN Sequence Number Description | acetaminophen TABLET ER 650 MG ORAL |
HIC3 | H3E |
HIC3 Description | ANALGESIC/ANTIPYRETICS,NON-SALICYLATE |
GCN | 16910 |
HICL Sequence Number | 001866 |
HICL Sequence Number Description | ACETAMINOPHEN |
Brand/Generic | Generic |
Proprietary Name | mapap arthritis pain |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Acetaminophen |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 650 |
Active Ingredient Units | mg/1 |
Substance Name | ACETAMINOPHEN |
Labeler Name | Major Pharmaceuticals |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA075077 |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 00904-5769-60 (00904576960)
NDC Package Code | 0904-5769-60 |
---|---|
Billing NDC | 00904576960 |
Package | 1 BOTTLE in 1 CARTON (0904-5769-60) / 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE |
Marketing Start Date | 2006-02-16 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.06585 |
Pricing Unit | EA |
Effective Date | 2022-11-23 |
NDC Description | MAPAP ARTHRITIS ER 650 MG CPLT |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2022-11-23 |
Standard Product Labeling (SPL)/Prescribing Information SPL 61f212a4-3748-4782-95ce-5434f931b4f4 Details
Uses
Warnings
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
- •
- more than 6 caplets in 24 hours, which is the maximum daily amount
- •
- with other drugs containing acetaminophen
- •
- 3 or more alcoholic drinks every day while using this product
Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:
- •
- skin reddening
- •
- blisters
- •
- rash
If a skin reaction occurs, stop use and seek medical help right away.
Do not use
- •
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- •
- if you are allergic to acetaminophen or any of the inactive ingredients in this product
Directions
- •
- do not take more than directed (see overdose warning)
adults |
|
under 18 years of age |
|
Other information
Inactive ingredients
Principal Display Panel
MAJOR®
Push & Turn Cap
Mapap® ARTHRITIS PAIN
ACTUAL SIZE
ACETAMINOPHEN EXTENDED-RELEASE TABLETS, 650 mg
CAPLETS
PAIN RELIEVER/FEVER REDUCER
FOR THE TEMPORARY RELIEF OF MINOR ARTHRITIS PAIN
Compare to the active ingredient in Tylenol® 8HR Arthritis Pain
DO NOT USE WITH OTHER MEDICINES CONTAINING ACETAMINOPHEN
100 Caplets* 650 mg. Each
*Capsule-Shaped Tablets
INGREDIENTS AND APPEARANCE
MAPAP ARTHRITIS PAIN
acetaminophen tablet, film coated, extended release |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Labeler - Major Pharmaceuticals (191427277) |